L1CAM and cancer: Targeting L1CAM protein in cancer cells is currently being evaluated by various approaches, including neutralizing antibodies [23], bispecific antibodies [24], radioimmunoconjugates [25] and chimeric antigen receptor-redirected T (CAR-T) cells [26].